Cellebrite DI Ltd. CEO Thomas E. Hogan sold approximately 103,000 shares of common stock on July 2, 2026, in a non-discretionary transaction to fulfill tax liabilities from vesting restricted stock units. The sale, valued at roughly $1.6 million based on a weighted-average price of $15.76 per share, leaves Hogan with a direct holding of 590,777 shares, representing a 0.24% ownership stake. Cellebrite, a digital intelligence solutions provider headquartered in Petah Tikva, reported trailing twelve-month revenue of $496.4 million and net income of $71.9 million, with a market capitalization of $4.1 billion as of July 6, 2026. The company recently received FedRAMP high authorization to operate, a certification held by fewer than 100 companies, and grew sales by 19% in its latest quarter.
Cellebrite DICEO sold 103k shares to cover tax liabilities, a routine insider sale that may signal lack of buying conviction.